OpenAlex
PricingAboutJobs
Log inGet started
Work

Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

PubMed

Year: 2002
Type: article
Source: PubMed
Authors: Louise R Howe, Kotha Subbaramaiah, Jay Patel, Jaime L Masferrer, Aparna Deora, Clifford Hudis, Howard T Thaler, William J Muller, Baoheng Du, Anthony M C Brown, Andrew J Dannenberg
Institutions: Cornell University, Weill Cornell Medicine
Language: English

Topic: Inflammatory mediators and NSAID effects
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: celecoxib, COX-2 inhibitors, HER2/neu, breast cancer, prostaglandin E2, PGE2 receptors, mammary carcinogenesis, chemoprevention
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: NEW THARAPY FOR HER 2/NEU POSITIVE BREAST CANCER
OpenAlex ID: W1754585763
FWCI: 14.56
Cites: 25
Cited by: 219
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms